Tech Company Financing Transactions
InVasic Therapeutics Funding Round
InVasic Therapeutics secured a $3.2 million funding round on 7/9/2010. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/9/2010
Transaction Type
Venture Equity
Amount
$3,150,000
Round
Undisclosed
Investors
Proceeds Purpose
The company plans to file an IND later this year for INV-144 targeting the slowing of the progression of chronic kidney disease in hypertensive diabetic patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2635 Walnut St.
Denver, CO 80205
USA
Denver, CO 80205
USA
Phone
Website
Email Address
Overview
InVasc is a clinical stage biopharmaceutical company developing drugs to treat or prevent cardiometabolic disease. We are currently focused on advancing our two lead drugs for Chronic Kidney Disease and Atherosclerosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Johnston
Chief Operating Officer
William Schaeffer
Browse more venture capital transactions:
Prev: 7/9/2010: Theranos venture capital transaction
Next: 7/11/2010: DocuSign venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs